Dr James Watson

Sir Henry Dale Fellow

Dr James Watson is a statistician interested in improving the treatment of infectious diseases of global health importance.

His main work focuses on severe malaria, notably improving the definition of severe malaria in areas of high malaria transmission. We have estimated that a third of children diagnosed with severe malaria in high transmission settings, in fact, have another cause of severe illness.

Additionally, he is an investigator and study statistician for PLATCOV, a platform trial characterising in vivo antiviral effects of repurposed or novel drugs for COVID-19; and the CHARM project, which aims to develop a new methodology for the assessment of new antiparasitic drugs for the treatment of Chagas disease.

Publications

Ruan Spies, Hanh N Hong, Phu P Trieu, Luong K Lan, Kim Lan, N N Hue, Nguyen T L Huong, Tran T L N Thao, Nguyen L Quang, Thu D D Anh, Truong V Vinh, Dang T M Ha, Phan T Dat, Nguyen P Hai, Le H Van, Guy E Thwaites, Nguyen T T Thuong, James A Watson, Timothy M Walker

Emerg Infect Dis

March 1, 2024

DOI: 10.3201/eid3003.231309

James A Watson, Thomas J Peto, Nicholas J White

PLoS Med

November 9, 2023

DOI: 10.1371/journal.pmed.1004312

Megha Rajasekhar, Julie A Simpson, Benedikt Ley, Peta Edler, Cindy S Chu, Tesfay Abreha, Ghulam R Awab, J Kevin Baird, Germana Bancone, Bridget E Barber, Matthew J Grigg, Jimee Hwang, Harin Karunajeewa, Marcus V G Lacerda, Simone Ladeia-Andrade, Alejandro Llanos-Cuentas, Sasithon Pukrittayakamee, Komal R Rijal, Kavitha Saravu, Inge Sutanto, Walter R J Taylor, Kamala Thriemer, James A Watson, Philippe J Guerin, Nicholas J White, Ric N Price, Robert J Commons; WorldWide Antimalarial Resistance Network (WWARN) Vivax Primaquine Dosing Efficacy, Tolerability and Safety Study Group

Lancet Infect Dis

September 22, 2023

DOI: 10.1016/S1473-3099(23)00431-0

Robert J Commons, Megha Rajasekhar, Peta Edler, Tesfay Abreha, Ghulam R Awab, J Kevin Baird, Bridget E Barber, Cindy S Chu, Liwang Cui, Andr%E9 Daher, Lilia Gonzalez-Ceron, Matthew J Grigg, Jimee Hwang, Harin Karunajeewa, Marcus V G Lacerda, Simone Ladeia-Andrade, Kartini Lidia, Alejandro Llanos-Cuentas, Rhea J Longley, Dhelio B Pereira, Ayodhia P Pasaribu, Sasithon Pukrittayakamee, Komal R Rijal, Inge Sutanto, Walter R J Taylor, Pham V Thanh, Kamala Thriemer, Jos%E9 Luiz F Vieira, James A Watson, Lina M Zuluaga-Idarraga, Nicholas J White, Philippe J Guerin, Julie A Simpson, Ric N Price; WorldWide Antimalarial Resistance Network (WWARN) Vivax Primaquine Dosing Efficacy, Tolerability and Safety Study Group

Lancet Infect Dis

September 22, 2023

DOI: 10.1016/S1473-3099(23)00430-9